Package 63323-325-10

{"route": ["INTRAVENOUS"], "spl_id": "fc30a93e-1fe1-478d-bf68-fe8ab2575279", "openfda": {"upc": ["0363323325091", "0363323325039"], "unii": ["927L42J563"], "rxcui": ["1734932", "1734934"], "spl_set_id": ["cb64dfab-52ee-4312-bc9c-c3d04efe9109"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 TRAY (63323-325-10)  / 10 mL in 1 VIAL, SINGLE-DOSE (63323-325-03)", "package_ndc": "63323-325-10", "marketing_start_date": "20001017"}, {"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 TRAY (63323-325-20)  / 20 mL in 1 VIAL, SINGLE-DOSE (63323-325-09)", "package_ndc": "63323-325-20", "marketing_start_date": "20001017"}], "brand_name": "Acyclovir", "product_id": "63323-325_fc30a93e-1fe1-478d-bf68-fe8ab2575279", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "63323-325", "generic_name": "Acyclovir", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR SODIUM", "strength": "50 mg/mL"}], "application_number": "ANDA074930", "marketing_category": "ANDA", "marketing_start_date": "20001017", "listing_expiration_date": "20261231"}